Migraine symptoms related to the percutaneous closure of an ostium secundum atrial septal defect: Report of four paediatric cases and review of the literature

Cephalalgia

Volumn 27, Issue 6, 2007, Pages 550-556

  Fernandez Mayoralas D M ^a   Fernandez Jaen A ^a   Munoz Jareno N ^a   Gutierrez Larraya F ^a   Calleja Perez B ^a   San Antonio Arce, V ^b  

^a Hospital de la Zarzuela   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Amplatzer; Atrial septal defect; Clopidogrel; Migraine

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COURSE EVALUATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HUMAN; MALE; MIGRAINE; PRESCHOOL CHILD; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADOLESCENT; CARDIAC SURGICAL PROCEDURES; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; MIGRAINE DISORDERS; POSTOPERATIVE COMPLICATIONS; PROSTHESES AND IMPLANTS;

EID: 34249810638     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01331.x     Document Type: Article

References (33)

1. Domínguez-Salgado M, Santiago-Gómez R, Campos- Castelló J, Fernández MJ. La cefalea en la infancia, una aproximación diagnostica. Anales Españoles Pediatría 2002 57 : 432 43.
2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 24 (Suppl. 1 1 160.
3. Rodes-Cabau J, Molina C, Serrano-Munuera C, Casaldaliga J, Alvarez-Sabin J, Evangelista A et al. Migraine with aura related to the percutaneous closure of an atrial septal defect. Catheter Cardiovasc Interv 2003 60 : 540 2.
4. Sharifi M, Burks J. Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv 2004 63 : 255.
5. Willmshurst P, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000 356 : 1648 51.
6. Yankovsky AE, Kuritzky A. Transformation into daily migraine with aura following transcutaneous atrial septal defect closure. Headache 2003 43 : 496 8.
7. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999 52 : 1622 5.
8. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997 42 : 388 93.
9. Diener HC, Weimar C, Katsarava Z. Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol 2005 18 : 299 304.
10. Conejo L. Defectos septales auriculares. In : García S, editor. Protocolos de la Sociedad Española de Cardiología Pediátrica. Available at http://www.secardioped.org/protocolos/ protocolos/Capitulo_4.pdf 2002. Last accessed 14 December 2006.
11. Tsimikas S. Transcatheter closure of patent foramen ovale for migraine prophylaxis: hope or hype? J Am Coll Cardiol 2005 45 : 496 8.
12. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003 107 : 5 9.
13. Tobis MJ, Azarbal B. Does patent foramen ovale promote cryptogenic stroke and migraine headache? Tex Heart Inst J 2005 32 : 362 5.
14. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006 47 : 440 5.
15. Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005 6 : 328 30.
16. Giardini A, Donti A, Formigari R, Salomone L, Prandstraller D, Bonvicini M et al. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006 151 : 922 5.
17. Morandi E, Anzola GP, Casilli F, Onorato E. Migraine: traditional or 'innovative' treatment? A preliminary case-control study. Pediatr Cardiol 2005 26 : 231 3.
18. Spies C, Schrader R. Transcatheter closure of patent foramen ovale in patients with migraine headache. J Interv Cardiol 2006 19 : 552 7.
19. Sharifi M, Dehghani M, Mehdipour M, Al-Bustami O, Emrani F, Burks J. Intense migraines secondary to percutaneous closure of atrial septal defects. J Interv Cardiol 2005 18 : 181 3.
20. Riederer F, Kaya M, Plank C, Gabriel H, Wessely P. Migraine with aura related to closure of atrial septal defects. Headache 2005 45 : 953 6.
21. Mortelmans K, Post M, Thijs V, Herroelen L, Budts W. The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 2005 26 : 1533 7.
22. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005 45 : 493 5.
23. Schwerzmann M, Nedeltchef K, Mattle HP. Presumed paradoxical embolism and migraine with aura. Circulation 2003 108 (Suppl. 4 1631.
24. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005 45 : 489 92.
25. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003 16 : 39 42.
26. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004 62 : 1439 40.
27. Kruit MC, van Buchem MA, Hofman PA, Bakkers JTN, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA 2004 291 : 427 34.
28. Choudhuri R, Cui L, Yong C, Bowyer S, Klein RM, Welch KM et al. Cortical spreading depression and gene regulation: relevance to migraine. Ann Neurol 2002 51 : 499 506.
29. Gupta VK. Closure of atrial septal defect and migraine. Headache 2004 44 : 291 2.
30. Tietjen GE. Stroke and migraine linked by silent lesions. Lancet Neurol 2004 3 : 267.
31. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005 91 : 1173 5.
32. Finkelstein Y, Nurmohamed L, Avner M, Benson LN, Koren G. Clopidogrel use in children. J Pediatr 2005 147 : 657 61.
33. Soman T, Rafay MF, Hune S, Allen A, MacGregor D, deVeber G. The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke 2006 37 : 1120 2.